Bloomberg Law
Aug. 26, 2022, 2:48 PM UTC

Moderna Sues Pfizer, BioNTech Over Covid Vaccine Technology (2)

Angelica Peebles
Angelica Peebles
Bloomberg News
Robert Langreth
Robert Langreth
Bloomberg News

Moderna Inc. sued Pfizer Inc. and <-rte-company state="{"_id":"00000182-daa2-da0b-a1a3-fbbf9dd60002","_type":"00000160-4b23-d8bd-adfd-4b3348fd0000"}">BioNTech SE, claiming the technology in their Covid-19 shot infringes on its patents, a move that sets the stage for a massive legal clash between the vaccine titans.

Moderna <-bsp-bb-link state="{"bbDocId":"RH81CVDWRGG2","_id":"00000182-daa2-da0b-a1a3-fbbf9dd60003","_type":"0000016b-944a-dc2b-ab6b-d57ba1cc0000"}">accused Pfizer and BioNTech of violating intellectual property rights on key elements of its messenger RNA technology in developing the Comirnaty vaccine. Cambridge, Massachusetts-based Moderna said it had patents from 2010 to 2016 on the mRNA technology that made its Spikevax shot possible but that the other two companies copied the technology without permission.

Pfizer and BioNTech “took four different candidates into clinical testing, ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.